Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 6Not yet recruiting 4Recruiting 3Withdrawn 2Terminated 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2CNS 1

Conditions

Thyroid Neoplasms 1Hypothyroidism 1Brain Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Thyroxine × Clear all
NCT02946918 2020-12-01

Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy

University of Texas Southwestern Medical Center

Phase 4 Terminated
14 enrolled 9 charts
Head & Neck

Thyroid Neoplasms

NCT00488644 2013-06-24

Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors

M.D. Anderson Cancer Center

Phase NA Terminated
12 enrolled 3 charts
CNSHead & Neck

Brain Neoplasms, Hypothyroidism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡